TY - JOUR
T1 - Reactivation of Atp4a concomitant with intragenic DNA demethylation for cancer inhibition in a gastric cancer model
AU - Cao, Donghui
AU - Zhao, Dan
AU - Jia, Zhifang
AU - Su, Tongrong
AU - Zhang, Yangyu
AU - Wu, Yanhua
AU - Wu, Menghui
AU - Tsukamoto, Tetsuya
AU - Oshima, Masanobu
AU - Jiang, Jing
AU - Cao, Xueyuan
N1 - Publisher Copyright:
© 2019
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Accumulating evidence suggests that aberrant DNA methylation and gene silencing of tumor suppressors are pervasive in gastric malignancies, supporting reactivation of tumor suppressors through DNA demethylation as a potential therapeutic opportunity. Atp4a is an important tumor suppressor gene, encoding H+, K+-ATPase, and mediating gastric acid secretion in the stomach. Using transgenic gastric cancer model K19-Wnt1/C2mE (Gan) mice, by combining the transcriptome and MeDIP (methylated DNA immunoprecipitation) sequencing, together with qRT-PCR, we showed that Atp4a was expressed at low levels in tumor tissues and multiple GC cells, while both 5-aza-CdR and 18β-glycyrrhetinic acid (GRA) pharmacological treatment triggered Atp4a activation with downregulation of DNMT1. In addition, CpG island (CGI) search showed that the CpG rich region is absent in the promoter region but present in exons 9–14 of Atp4a. Methylation specific PCR (MSP) indicated that Atp4a was fully or partly methylated in multiple GC cells. Further MassArray suggested that the demethylation in the CpG site 75, 183, 196, 262–268 might be responsible for the reactivation of Atp4a. Our research identified that GRA, a bioactive component found in abundance in Radix Glycyrrhiza, reactivated Atp4a expression and inhibited gastric tumorigenesis as a potential demethylation agent.
AB - Accumulating evidence suggests that aberrant DNA methylation and gene silencing of tumor suppressors are pervasive in gastric malignancies, supporting reactivation of tumor suppressors through DNA demethylation as a potential therapeutic opportunity. Atp4a is an important tumor suppressor gene, encoding H+, K+-ATPase, and mediating gastric acid secretion in the stomach. Using transgenic gastric cancer model K19-Wnt1/C2mE (Gan) mice, by combining the transcriptome and MeDIP (methylated DNA immunoprecipitation) sequencing, together with qRT-PCR, we showed that Atp4a was expressed at low levels in tumor tissues and multiple GC cells, while both 5-aza-CdR and 18β-glycyrrhetinic acid (GRA) pharmacological treatment triggered Atp4a activation with downregulation of DNMT1. In addition, CpG island (CGI) search showed that the CpG rich region is absent in the promoter region but present in exons 9–14 of Atp4a. Methylation specific PCR (MSP) indicated that Atp4a was fully or partly methylated in multiple GC cells. Further MassArray suggested that the demethylation in the CpG site 75, 183, 196, 262–268 might be responsible for the reactivation of Atp4a. Our research identified that GRA, a bioactive component found in abundance in Radix Glycyrrhiza, reactivated Atp4a expression and inhibited gastric tumorigenesis as a potential demethylation agent.
UR - http://www.scopus.com/inward/record.url?scp=85077237554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077237554&partnerID=8YFLogxK
U2 - 10.1016/j.lfs.2019.117214
DO - 10.1016/j.lfs.2019.117214
M3 - Article
C2 - 31884095
AN - SCOPUS:85077237554
SN - 0024-3205
VL - 242
JO - Life Sciences
JF - Life Sciences
M1 - 117214
ER -
